Table 4

Conditional logistic regression results for various diseases of interest

Mortality odds ratio (95% confidence interval) by silica exposure category
DiseaseEver* low/noMedium v low/noHigh v low/noSuper high v low/noTrend direction, p value
COPD, chronic obstructive pulmonary disease; NS, non-significant.
*Ever = medium, high, and super high categories combined.
+, increasing disease risk with increasing crystalline silica exposure category; −, decreasing disease risk with increasing crystalline silica exposure category.
Silicosis4.98 (4.35 to 5.71)2.91 (2.43 to 3.48)6.84 (5.73 to 8.16)30.5 (18.4 to 50.5)+, p<0.001
Lung cancer0.99 (0.98 to 1.00)0.88 (0.87 to 0.90)1.13 (1.11 to 1.15)1.13 (1.06 to 1.21)+, p<0.001
Stomach cancer0.98 (0.95 to 1.02)0.95 (0.91 to 1.00)1.04 (0.99 to 1.09)0.81 (0.64 to 1.03)−, NS
Oesophageal cancer0.94 (0.91 to 0.98)0.85 (0.81 to 0.89)1.07 (1.01 to 1.13)1.14 (0.90 to 1.43)−, NS
COPD1.12 (1.10 to 1.14)1.02 (0.99 to 1.04)1.29 (1.25 to 1.33)1.47 (1.30 to 1.66)+, p<0.001
Pulmonary tuberculosis1.47 (1.37 to 1.57)1.34 (1.23 to 1.47)1.60 (1.45 to 1.76)2.48 (1.68 to 3.65)+, p<0.001
Sarcoidosis0.66 (0.54 to 0.80)0.73 (0.57 to 0.94)0.58 (0.44 to 0.76)1.02 (0.29 to 3.56)−, NS
Systemic sclerosis1.00 (0.84 to 1.19)0.91 (0.72 to 1.14)1.08 (0.84 to 1.40)2.14 (0.82 to 5.57)+, NS
Systemic lupus erythematosus0.94 (0.80 to 1.10)0.88 (0.72 to 1.08)1.01 (0.79 to 1.29)1.37 (0.51 to 3.69)−, NS
Rheumatoid arthritis1.19 (1.12 to 1.25)1.23 (1.15 to 1.31)1.11 (1.01 to 1.22)1.05 (0.70 to 1.57)+, p<0.001
All renal failure0.98 (0.97 to 0.99)0.99 (0.98 to 1.01)0.96 (0.94 to 0.98)1.01 (0.92 to 1.10)−, p<0.001
Acute renal failure0.97 (0.94 to 1.00)0.96 (0.93 to 1.00)0.99 (0.95 to 1.04)1.01 (0.82 to 1.24)−, NS
Chronic renal failure0.96 (0.94 to 0.99)0.98 (0.95 to 1.01)0.93 (0.89 to 0.98)1.00 (0.83 to 1.21)−, p=0.003
Chronic glomerulonephritis0.90 (0.85 to 0.96)0.93 (0.87 to 1.00)0.85 (0.77 to 0.94)0.70 (0.45 to 1.10)−, p<0.001
Membranous glomerulonephritis0.89 (0.53 to 1.48)0.93 (0.47 to 1.85)0.89 (0.45 to 1.77)−, NS